Final Program - American Society of Gene & Cell Therapy
Final Program - American Society of Gene & Cell Therapy
Final Program - American Society of Gene & Cell Therapy
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Abstract Directory, Saturday, May 18, 2013<br />
Saturday, May 18, 2013<br />
Poster Session III, continued<br />
3:45 PM - 5:45 PM<br />
Room: Exhibit Hall C/D<br />
Cancer-Targeted <strong>Gene</strong> & <strong>Cell</strong> <strong>Therapy</strong>: <strong>Cell</strong><br />
<strong>Therapy</strong> / Immunotherapy / <strong>Cell</strong>ular Targets<br />
654<br />
Combination <strong>of</strong> CD3+CD56+ (NKT) <strong>Cell</strong>s<br />
Immunotherapy and Adenovirus-p53 <strong>Gene</strong> <strong>Therapy</strong> for<br />
Head and Neck Squamous <strong>Cell</strong> Carcinoma<br />
Hiroki Saito, Naoya Morishita, Kyung-Mi Lee, Dante Dator, Masato<br />
Kawabata, Masato Fujisawa, Toshiro Shirakawa.<br />
655<br />
Interfering Peptides Targeting Transcription Factor<br />
AP1 for Pancreatic Cancer <strong>Gene</strong> <strong>Therapy</strong><br />
Soukaina Rejiba, Megan Frelan, Alex Hermann, Katja Arndt, Amor<br />
Hajri.<br />
656<br />
JMJD3 Regulates Senescence-Associated Secretory<br />
Phenotype Factors Responsible for Robust Neural Stem<br />
<strong>Cell</strong> Tropism toward Glioma<br />
Michael E. Silva, Patrick M. Perrigue, Daniel Mota, Lauren Joseph,<br />
Nathan Feng, Michael Reid, Joseph Najbauer, Karen S. Aboody.<br />
657<br />
Bioengineering ACE Synthetic Chromosomes for Anti-<br />
Cancer <strong>Gene</strong> <strong>Therapy</strong><br />
Edward Perkins, Jon Holy, Teresa Rose-Hellkant, Amy Greene.<br />
658<br />
DNA Vaccine with scFv6.C4 Prevent the Growth <strong>of</strong><br />
Tumor Expressing CEA<br />
Priscila M. A. Denapoli, Roberta S. Stilhano, Priscila K. Matsumoto,<br />
Carolina B. Parise, Jane Z. de Moraes, Wolfgang Zimmermann, Sang<br />
W. Han.<br />
659<br />
Presumptive Oncogenic Transcriptional Factor PDX1<br />
Regulates Pancreatic Cancer Via an Ampliication Loop<br />
Involving the RAS, PI3K and p53 Signaling Pathways<br />
Juehua Yu, Guisheng Zhou, Shi-he Liu, James Wu, John Nemunaitis,<br />
Neil Senzer, Donald Rao, Enrique Rosengurt, F. C. Brunicardi.<br />
660<br />
Targeting Lysosome Integrity as a Method To Restore<br />
Sensitivity to Ceramide-Induced <strong>Cell</strong> Death<br />
Lorianne S. Turner, Krissy Smith, Lenton Holley, Christopher<br />
Johnson, Timothy Prince, Heather Yancey.<br />
Hematologic and Immunologic <strong>Gene</strong> & <strong>Cell</strong><br />
<strong>Therapy</strong> II<br />
661<br />
Lentiviral <strong>Gene</strong> <strong>Therapy</strong> <strong>of</strong> RAG Severe Combined<br />
Immunodeiciency<br />
Niek P. van Til, Guus van der Velden, Helen de Boer, Pietro L.<br />
Poliani, Michael N. Antoniou, Anna Villa, Chantal Lagresle-Peyrou,<br />
Marina Cavazzana-Calvo, Fang Zhang, Adrian J. Thrasher, Gerard<br />
Wagemaker.<br />
662<br />
Stem <strong>Cell</strong> and T-<strong>Cell</strong> <strong>Gene</strong> <strong>Therapy</strong> Using SIN-<br />
Lentiviral Vector in Type 3 Familial Hematophagocytic<br />
Lymphohistocytosis: A Comparative Approach<br />
Julie Rivière, Tayebeh Soheili, Els Verhoeyen, Anne Galy, <strong>Gene</strong>viève<br />
De Saint Basile, Marina Cavazzana-Calvo.<br />
663<br />
High Expression Bioengineered Factor VIII Enables<br />
AAV-Based <strong>Gene</strong> <strong>Therapy</strong> <strong>of</strong> Hemophilia A<br />
H. Trent Spencer, Harrison C. Brown, Jordan E. Shields, J. Fraser<br />
Wright, Christopher B. Doering.<br />
664<br />
Identiication <strong>of</strong> Novel Combination <strong>of</strong> Elements in<br />
cHS4 with Optimal Insulator Activity and Improved<br />
Titers in g-Globin Carrying SIN Lentiviral Vectors<br />
Paritha Arumugam, Michael Wourms, Joseph Starnes, Catherine<br />
Fox, Xiaoming Li, Punam Malik.<br />
665<br />
Intraosseous Delivery <strong>of</strong> Lentiviral Vectors Expressing<br />
Factor VIII under the Control <strong>of</strong> the Platelet-Speciic<br />
Glycoprotein 1ba Promoter Leads to Long-Term<br />
Correction <strong>of</strong> Bleeding in Hemophilia A Mice<br />
Xuefeng Wang, Andy Chiang, Simon C. Shin, Liping Chen, Dao Pan,<br />
David J. Rawlings, Carol H. Miao.<br />
666<br />
Lentiviral Vectors Tailored for Liver-Directed <strong>Gene</strong><br />
<strong>Therapy</strong> Do Not Show Any Detectable Genotoxicity in<br />
Sensitive In Vivo Biosafety Assays<br />
Marco Ranzani, Alessio Cantore, Monica Volpin, Pierangela Gallina,<br />
Stefano Annuziato, Francesca Sanvito, Fabrizio Benedicenti,<br />
Cynthia Bartholomae, Lucia Sergi Sergi, Christ<strong>of</strong> von Kalle,<br />
Manfred Schmidt, Claudio Doglioni, Luigi Naldini, Eugenio<br />
Montini.<br />
667<br />
Successful Liver <strong>Gene</strong> <strong>Therapy</strong> <strong>of</strong> Hemophilia B<br />
Dogs Using Lentiviral Vectors and Hyperfunctional<br />
Transgene<br />
Alessio Cantore, Patrizia Della Valle, Sara Bartolaccini, Lucia Sergi<br />
Sergi, Thierry VandenDriessche, Marinee Chuah, Dwight Bellinger,<br />
Armando D’Angelo, Timothy Nichols, Luigi Naldini.<br />
136<br />
<strong>Final</strong> <strong>Program</strong> SALT LAKE CITY, UTAH May 15–18, 2013
Change language